International prices and availability of pharmaceuticals in 2005
International prices and availability of pharmaceuticals in 2005
复制标题
DOI：
10.1377/hlthaff.27.1.221
复制
发表时间：
2008-01-01
期刊：
影响因子：
9.7
通讯作者：
Furukawa, Michael F.
中科院分区：
文献类型：
--
作者：
Danzon, Patricia M.;Furukawa, Michael F.
本文比较了2005年12个国家的药品支出、可得性、使用和价格。美国的人均药品支出高于其他国家。美国对新药和高强度配方的使用相对较高；其他国家使用的是更老的药物和更弱的配方。因此，美国的总体使用量是低还是高取决于产品的数量和类型。综合物价指数显示，国外价格比美国制造价格低20- 40%，但只比美国公共价格低10- 30%。仿制药在美国比在其他国家便宜。
This paper compares pharmaceutical spending, availability, use, and prices in twelve countries in 2005. Drug spending per capita was higher in the United States than in other countries. The United States had relatively high use of new drugs and high-strength formulations; other countries used more of older drugs and weaker formulations. Thus, whether U.S. overall volume of use is lower or higher depends on the measure of volume and type of product. Comprehensive price indexes show foreign prices to be 20-40 percent lower than U.S. manufacturer prices, but only 10-30 percent lower than U.S. public prices. Generics are cheaper in the United States than in other countries.